Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry
Majzoub, Ahmad
Researchers analyze its structure and peptide-related interactions within experimental research models
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
the measure is co-financed with tax funds on the basis of the budget passed by the Saxon state parliament (to M.F.), Deutsche Forschungsgemeinschaft (FE 1236/5-1 to M.F.) and Bundesministerium fr Bildung und Forschung (01EJ2205A, FERROPath to M.F.)
US$ 26.72
US$ 26.53
US$ 22.15
US$ 20.00
US$ 22.54
US$ 20.75
US$ 26.64
